Integrated Diagnostics (LON:IDHC) Sets New 1-Year Low – Time to Sell?

Integrated Diagnostics Holdings plc (LON:IDHC) shares hit a new 52-week low during mid-day trading on Thursday. The company traded as low as GBX 0.45 and last traded at GBX 0.46, with a volume of 71,464 shares changing hands. The stock had previously closed at GBX 0.46.

Integrated Diagnostics Trading Down 0.4%

The firm has a market cap of £2.67 million, a price-to-earnings ratio of 0.00, a price-to-earnings-growth ratio of 7.65 and a beta of 0.44. The company has a 50 day moving average price of GBX 0.52 and a 200 day moving average price of GBX 0.56. The company has a debt-to-equity ratio of 42.91, a quick ratio of 0.75 and a current ratio of 1.67.

Integrated Diagnostics Company Profile

IDH is a leading diagnostics services provider in the Middle East and Africa offering a broad range of clinical pathology and
radiology tests to patients in Egypt, Jordan, Nigeria, Saudi Arabia, and Sudan. The Group’s core brands include Al Borg, Al Borg
Scan and Al Mokhtabar in Egypt, as well as Biolab (Jordan), Echo-Lab (Nigeria), Ultralab and Al Mokhtabar Sudan (both in Sudan),
and Biolab KSA (Saudi Arabia). With over 40 years of experience, a long track record for quality and safety has earned the Company
a trusted reputation, as well as internationally recognised accreditations for its portfolio of over 3,000 diagnostics tests.